Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ligand Pharmaceuticals revenue
Ligand Pharmaceuticals's revenue is $241.5 million.
What is Ligand Pharmaceuticals's revenue?
- Ligand Pharmaceuticals's revenue growth from 2009 to 2021 is 520.3%.
- Ligand Pharmaceuticals has 116 employees, and the revenue per employee ratio is $2,082,275.
- Ligand Pharmaceuticals's peak quarterly revenue was $51.8M in 2024(q3).
- Ligand Pharmaceuticals peak revenue was $251.5M in 2018.
- Ligand Pharmaceuticals annual revenue for 2020 was 163.6M, 35.98% growth from 2019.
- Ligand Pharmaceuticals annual revenue for 2021 was 241.5M, 47.68% growth from 2020.
On this page
Zippi applies for you, and finds you a job.
Ligand Pharmaceuticals historical revenue
Ligand Pharmaceuticals's peak revenue was $251.5M in 2018. The peak quarterly revenue was $51.8M in 2024(q3).
Ligand Pharmaceuticals's revenue increased from $38.9m in 2009 to $241.5M currently. That's a 520.3% change in annual revenue.
Ligand Pharmaceuticals annual revenue
Ligand Pharmaceuticals annual revenue over time
| Fiscal year / year | Ligand Pharmaceuticals revenue |
|---|---|
| 2009 | $38.9M |
| 2010 | $23.5M |
| 2011 | $30.0M |
| 2012 | $31.4M |
| 2013 | $49.0M |
| 2014 | $64.5M |
| 2015 | $71.9M |
| 2016 | $109.0M |
| 2017 | $141.1M |
| 2018 | $251.5M |
| 2019 | $120.3M |
| 2020 | $163.6M |
| 2021 | $241.5M |
How accurately did Ligand Pharmaceuticals' revenue projections match actual performance?
Ligand Pharmaceuticals annual growth
Ligand Pharmaceuticals saw the greatest revenue growth in 2018, when revenue increased by 78.21%.
Ligand Pharmaceuticals had the lowest revenue growth in 2019, when revenue changed by -52.17%.
Ligand Pharmaceuticals annual growth rate over time
| Year | Ligand Pharmaceuticals growth |
|---|---|
| 2010 | -40%↓ |
| 2011 | 28%↑ |
| 2012 | 4%↑ |
| 2013 | 56%↑ |
| 2014 | 32%↑ |
| 2015 | 11%↑ |
| 2016 | 52%↑ |
| 2017 | 29%↑ |
| 2018 | 78%↑ |
| 2019 | -52%↓ |
| 2020 | 36%↑ |
| 2021 | 48%↑ |
Ligand Pharmaceuticals jobs nearby
Do you work at Ligand Pharmaceuticals?
Did Ligand Pharmaceuticals meet its revenue projections?
Ligand Pharmaceuticals financial information
| CEO | John L. Higgins |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 116 |
| Date Founded | 1987 |
| Headquarters | San Diego, California |
| Number of Locations | 4 |
| Revenue | $241.5M |
| Net Income | -$33,361,000 |
| Gross Proft | $179.4M (2021) |
| EBITDA | $105.9M (2021) |
| PE Ratio | 44.71 |
| Tax Rate | -0.1% |
| Market Capitalization | $2.6B |
| Total Assets | $762,668,000 |
| Ticker | LGND |
Ligand Pharmaceuticals jobs you might like
Ligand Pharmaceuticals financing
Ligand Pharmaceuticals received early financing of $225.0M on 2014-08-14.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $225M | 08/2014 |
| Post Ipo Debt | $650M | 05/2018 |
Ligand Pharmaceuticals competitors
Ligand Pharmaceuticals's top competitor, Merck, earned an annual revenue of $64.2B.
Ligand Pharmaceuticals's smallest competitor is Delcath Systems with revenue of $37.2M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | $90,328 | $64.2B | 74,000 | 1,505 |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 645 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | - |
| Regeneron | $85,589 | $14.2B | 9,123 | 325 |
| Forest Laboratories | $91,901 | $3.6B | 6,200 | - |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Pharmaceutical | $74,717 | $2.7B | 5,700 | 116 |
| Cubist Pharmaceuticals | $91,725 | $926.4M | 873 | - |
| Hoffmann-LA Roche Inc | $93,461 | $60.9B | 101,200 | 173 |
Ligand Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Ligand Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ligand Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ligand Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ligand Pharmaceuticals. The data presented on this page does not represent the view of Ligand Pharmaceuticals and its employees or that of Zippia.
Ligand Pharmaceuticals may also be known as or be related to LIGAND PHARMACEUTICALS INC, Ligand Pharmaceuticals, Ligand Pharmaceuticals Incorporated, Ligand Pharmaceuticals, Inc. and Ligand Pharmaceuticals,Inc.